| Financial Year |
March 31 2023 |
| Monetary Funds |
1,003,892,917.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
658,365.12 |
| Accounts Receivable |
145,527,768.92 |
| Advances to Suppliers |
958,123.84 |
| Other Receivables |
33,000,448.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
68,912,408.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,806,221.17 |
| Total Current Assets |
1,282,596,643.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
12,604,880.79 |
| Investment Properties |
7,929,632.73 |
| Fixed Assetes |
1,486,737,545.66 |
| Under-construction Projects |
179,510,917.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,570,690,336.52 |
| R&D expenses |
-- |
| Goodwill |
38,792,845.96 |
| Long-Term Deferred and Prepaid Expenses |
11,643,769.55 |
| Deferred Income Tax Assets |
49,433,151.38 |
| Other Non-Current Assets |
3,658,760.67 |
| Sub-Total of Non-Current Assets |
3,412,880,340.37 |
| Total Assets |
4,695,476,983.68 |
| Short-Term Loans |
206,644,640.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
73,697,207.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,024,958.52 |
| Taxes Payable |
26,014,821.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
500,096,169.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
124,539,578.96 |
| Other Current Liabilities |
19,450,633.33 |
| Sub-Total of Current Liabilities |
1,023,612,859.55 |
| Long-term Loans |
356,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
19,724,092.09 |
| Deferred Income Tax Liabilities |
1,499,575.35 |
| Other Non-Current Liabilities |
124,668,957.15 |
| Sub-Total of Non-Current Liabilities |
540,562,429.48 |
| Total Liabilities |
1,564,175,289.03 |
| Paid-In Capital(Or Share Stock) |
617,518,730.00 |
| Capital Surplus |
549,480,495.84 |
| Surplus Reserve |
80,920,556.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,170,570,642.84 |
| Minority Stockholder's Interest |
702,412,138.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,428,889,556.15 |
| Owner's Equity（Stockholder's Equity） |
3,131,301,694.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,695,476,983.68 |
